Clinical Trial Detail

NCT ID NCT02415608
Title Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jason Robert Gotlib
Indications

mast cell neoplasm

mast-cell leukemia

Therapies

Ibrutinib

Age Groups: adult

No variant requirements are available.